Paper
Document
Download
Flag content
0

1069TiP A phase I/IIa dose escalation and expansion study of 23ME-01473, an anti-ULBP6/2/5 antibody, for patients with advanced solid malignancies

Save
TipTip
Document
Download
Flag content
0
TipTip
Save
Document
Download
Flag content